Anixa Biosciences, Inc.

US$3.17As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ANIXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (6.68%)
Div yield —
ROE (73.17%)
Biotechnology
Beta (5Y) 0.45
PE TTM —
TSR TTM (23.12%)
Mkt cap US$110.4M
ROIC (47.31%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.33
4.92%
(66.52%)
Hold 12|1|8|2|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.05
0.05
0.06
5.83%
8.09%
10.74%
12.75%
Revenue$M
10.20
9.974
10.50
11.03
2.35%
(3.35%)
1.64%
7.85%
Peers (US$110.4M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.221
0.134
0.138
EBIT/Intx
1.968
0.112
0.101
Own earn%
(38.23)
28.10
22.66
Sh yield%
22.26
34.26
30.85
Owners
Insiders/Inst%
1.33
57.57
Short interest%
3.74
SBC / revenue%
1.82
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
16–19
$1 testx
—
Incr. ROIC%
2